Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-018448
Filing Date
2022-05-17
Accepted
2022-05-17 18:12:49
Documents
2
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1548
2 EX-24 DOCUMENT attachment1.htm EX-24 4516
  Complete submission text file 0000899243-22-018448.txt   7467
Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Business Address
Smith Karen L. (Reporting) CIK: 0001639637 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 22936305

Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Issuer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)